![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Saturday, November 09, 2013 7:02:09 AM
Re: None
Post # of 37314
ARE WE ONLY LOOKING AT THE NEGATIVE OF THIS COMPANY?
Pharmagen Inc (OTCMKTS:PHRX) closed yesterday at $0.0049, a -26.87% decrease. Around 9.47 million shares were traded, beating an-average trading volume of 1.23 million shares. The company is now valued at around $2.58 million. Invivo Therapeutics Holdings Corp., a development stage company, focuses on developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries, peripheral nerve injuries, and other neurotrauma conditions.
http://www.sbwire.com/press-releases/momentum-stocks-in-focus-sk3-group-incotcmktsskto-pharmagen-incotcmktsphrx-invivo-therapeutics-holdings-corpotcmktsnviv-overseas-shipholding-group-incotcmktsosgiq-374284.htm
Full Time Employees: 27
http://finance.yahoo.com/q/pr?s=PHRX+
Recent PHRX News
- Specialty Pharma Company Moving Higher After Signing LOI for Pharmaceutical-Grade Cocaine • AllPennyStocks.com • 05/23/2024 04:34:00 PM
FEATURED Mawson Finland Provides Update on Exploration Activities at Rajapalot • Aug 21, 2024 9:06 AM
Unitronix Announces Strategic Entry into Cryptocurrency Space • UTRX • Aug 21, 2024 10:00 AM
Avant Technologies to Implement Robust Cybersecurity Measures for AI-Driven Healthcare Solutions • AVAI • Aug 21, 2024 8:00 AM
HealthLynked Corp. Announces Second Quarter and First Half 2024 Results: Continued Cost Reductions Set the Stage for Strategic Shift to App-Based Technology Services • HLYK • Aug 16, 2024 8:00 AM
PickleJar Announces Official Name Change and New Ticker Symbol • NREG • Aug 15, 2024 2:23 PM
VAYK's Q2 Profit Added to Accumulated Net Profit of Over $2.2 Million In 18 Months • VAYK • Aug 15, 2024 9:07 AM